跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,612 条关于
“Abbisko Therapeutics”
全部
16,612
临床试验
3,570
药物
3,114
机构
1,122
资讯
8,806
去年
Abbisko Therapeutics' Pimicotinib Achieves Primary Endpoints in Phase III Study for GIST
去年
Pimicotinib Shows Promise in Phase 2 Trial for Chronic Graft-versus-Host Disease
去年
Pimicotinib Shows Positive Phase 3 Results for Tenosynovial Giant Cell Tumor
去年
Abbisko's FGFR4 Inhibitor Irpagratinib Receives China's Breakthrough Therapy Designation for Hepatocellular Carcinoma
去年
Pimicotinib Shows Positive Phase 3 Results in Tenosynovial Giant Cell Tumors
去年
Pimicotinib Shows Significant Improvement in Tenosynovial Giant Cell Tumor Treatment
去年
Pimicotinib Shows Significant Efficacy in Phase III Trial for TGCT
2年前
Tenosynovial Giant Cell Tumors Treatment Market to See Significant Growth by 2034
去年
Pimicotinib Meets Primary Endpoint in Phase III Trial for Tenosynovial Giant Cell Tumor
3个月前
Abbisko Teams Up With Eli Lilly in Up to $1.9 Billion Oncology Drug Discovery Collaboration
第 1 页,共 881 页
上一页
下一页